- Price is above Fair Value, showing premium demand versus the model.
- Next-week expectancy is positive at 63.43% based on similar historical setup states.
UCB
BRU
Week ended 07 Aug 2026
Weekly Investor Report
UCB SA · Healthcare · Biotechnology
Latest close
223.1 EUR
0.1%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -11.1% below the Trend Line and sits at 38.0% of its 52-week range. The latest completed week returned 0.1%, after a -5.9% four-week move. The latest news-sentiment score is 59/100.
Setup score
39
out of 100
Latest Close
223.1 EUR
7 Aug 2026
1W Return
0.1%
latest completed week
4W Return
-5.9%
short-term follow-through
12W Return
-5.9%
quarterly tape
Trend Breadth
76.9%
40 of 52 weeks active
Volume Ratio
1.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- 7 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.1%
Latest completed week; four-week move -5.9%.
Indicator stack
42/36
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 63.43%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
59/100
4 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -11.1% below the Trend Line and sits at 38.0% of its 52-week range. The latest completed week returned 0.1%, after a -5.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5012-week average 0.48
12-week confirmation
Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.50Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers77 reversal markers
No recent accumulation markers. 7 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -5.9% over four weeks, -5.9% over 12 weeks, and 21.7% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year40
Trend breadth76.9%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.55Latest activity-pressure read.
Pressure change-48.0%Four-week change in activity pressure.
Leadership-15.72Latest relative-leadership reading.
RS change-118.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment59/100
Weighted news tone is neutral across 4 relevant articles.
2 positive · 2 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-22.4%Distance below the 52-week high.
13-week volatility5.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+6.7%Week of 13 Feb.
Worst week-9.4%Week of 24 Apr.
Latest week+0.1%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains11
Flat weeks0
Modest losses5
Sharp losses6
Recent vol5.0%13-week weekly-return volatility.
Base vol5.7%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew3.7% / -4.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorBE Healthcare
4-week rank9 / 12
Group average-2.8%
Trend breadth25.0%
Trend25.0%active weekly trend signals
MD25.0%positive activity pressure
RS8.3%positive relative leadership
Four-week leaders
IndustryBE Biotechnology
4-week rank7 / 9
Group average-1.1%
Trend breadth11.1%
Trend11.1%active weekly trend signals
MD22.2%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape40/100
Trend, activity pressure, participation, and risk combine to a 40/100 tape read.
Indicator analysis22/100Latest 12-week confirmation: trend 4/12, activity pressure 0/12, relative leadership 3/12.
Activity pressure 0.50; 7 reversal markers Next-Week ExpectancyPositive 63.43%Next-week expectancy is positive with a 63.43% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment59/100Weighted news tone is neutral across 4 relevant articles.
UCB SA (UCB) Stock Price Quote Today & Current Price Chart Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 223.1 EUR | 0.1% | 251.1 EUR | 170.0 EUR | -0.55 | -15.72 | 1.2M | Off |
| 31 Jul 2026 | 222.9 EUR | -9.4% | 252.1 EUR | 169.1 EUR | -0.48 | -14.44 | 1.9M | Off |
| 24 Jul 2026 | 246.0 EUR | 2.8% | 252.4 EUR | 168.2 EUR | -0.42 | -6.42 | 817.3K | Off |
| 17 Jul 2026 | 239.3 EUR | 0.9% | 252.0 EUR | 167.1 EUR | -0.41 | -7.10 | 734.7K | Off |
| 10 Jul 2026 | 237.1 EUR | -8.6% | 252.0 EUR | 166.1 EUR | -0.37 | -7.20 | 1.2M | Off |
| 3 Jul 2026 | 259.5 EUR | 0.4% | 251.9 EUR | 165.0 EUR | -0.24 | -2.07 | 131.9K | On |
| 26 Jun 2026 | 258.5 EUR | 3.5% | 251.5 EUR | 163.9 EUR | -0.30 | -0.89 | 197.8K | On |
| 19 Jun 2026 | 249.7 EUR | -9.2% | 250.8 EUR | 162.7 EUR | -0.38 | -2.39 | 436.1K | On |
| 12 Jun 2026 | 274.9 EUR | 5.3% | 250.2 EUR | 161.6 EUR | -0.58 | 6.19 | 169.0K | On |
| 5 Jun 2026 | 261.0 EUR | 3.7% | 248.5 EUR | 160.4 EUR | -0.96 | 4.18 | 221.2K | Off |
| 29 May 2026 | 251.7 EUR | 4.0% | 247.4 EUR | 159.3 EUR | -1.19 | 0.88 | 1.6M | Off |
| 22 May 2026 | 242.0 EUR | 2.1% | 246.3 EUR | 158.2 EUR | -1.36 | -2.71 | 1.1M | Off |
| 15 May 2026 | 237.0 EUR | 1.2% | 246.3 EUR | 157.1 EUR | -1.33 | -2.22 | 864.7K | Off |
| 8 May 2026 | 234.1 EUR | 1.9% | 246.7 EUR | 156.2 EUR | -1.04 | -3.01 | 1.1M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.